Hapbee Technologies Inc

Lungpacer Medical Inc., based in Vancouver, BC, is dedicated to developing innovative technologies aimed at improving patient outcomes in respiratory care. Their flagship product, the AeroPace System, has received approval from the United States Food and Drug Administration to enhance weaning success for adult patients on mechanical ventilation for at least 96 hours. In addition to the AeroPace System, Lungpacer is also working on the AeroNova System, which is currently limited to investigational use in clinical trials. The company emphasizes ongoing research and development to bring new solutions to the field of respiratory medicine. Generated from the website

Hapbee is a publicly traded wellness technology company based in Vancouver, British Columbia, specializing in innovative wearable devices designed to enhance sleep, focus, and overall mood without the use of pharmaceuticals. Utilizing patented ultra-low-frequency technology, Hapbee mimics the effects of natural compounds like melatonin and caffeine, allowing users to experience benefits such as relaxation and increased energy at the press of a button. Trusted by various health and performance experts, including athletes and wellness pioneers, Hapbee offers a unique alternative for those seeking to improve their mental and physical well-being. With products like the Hapbee Neckband and Sleep Pad, customers can enjoy clinically proven results backed by a 100-day money-back guarantee and one-year warranty. Generated from the website

Medeia-Vitalscan, located in West Vancouver, BC, specializes in providing advanced diagnostic tools for assessing autonomic nervous system (ANS), vascular, and sudomotor functions. Their flagship product, the VitalScan ANS System, offers quick and non-invasive testing to identify diseases associated with autonomic disorders. Physicians can efficiently evaluate patients for hidden illnesses within minutes, thanks to the FDA-cleared equipment. The SudoCheck System, another offering from Medeia-Vitalscan, focuses on evaluating sweat gland function and small nerve fiber regeneration. By combining galvanic skin response technology with quantitative sudomotor axon reflex testing, SudoCheck provides valuable insights into peripheral neuropathies and sudomotor function. This innovative system is designed to deliver immediate results within 3 minutes, making it a convenient tool for general practitioners, cardiologists, and neurologists. Generated from the website content